Vanta Bioscience Limited is an India-based preclinical contract research company. The Company provides services for testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers a host of preclinical safety assessment services for clients from pharmaceuticals, medical devices, nutraceuticals, feed additives, biotech, agrochemicals, cosmetics, and chemical industries. Additionally, it provides risk assessment services to evaluate the safety of active pharmaceutical ingredients, excipients, extractables, leachable, and pharmaceutical impurities resulting from the manufacturing process or product degradation. The Company’s services include discovery toxicology, agro-chemical and chemical safety, biocompatibility studies, diet formulation, and batch release tests. The Company has investments in one of its subsidiaries, Vantaclinical Research Limited.As of 25 May 2026, Vanta Bioscience Limited share price is ₹24.45. The stock opened at ₹24.45, compared to its previous close of ₹22.70. During today's trading session, Vanta Bioscience Limited share price moved in the range of ₹24.45 to ₹24.45, with an average price of ₹24.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹24.45 and a high of ₹24.45.
The market capitalization of Vanta Bioscience Limited is ₹14 Crs and a dividend yield of 0.00%.